RT Journal Article
SR Electronic
T1 Anticancer Potential of Oleuropein, the Polyphenol of Olive Oil, With 2-Methoxyestradiol, Separately or in Combination, in Human Osteosarcoma Cells
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 1243
OP 1251
DO 10.21873/anticanres.13234
VO 39
IS 3
A1 PAULINA PRZYCHODZEN
A1 ROKSANA WYSZKOWSKA
A1 MONIKA GORZYNIK-DEBICKA
A1 TOMASZ KOSTRZEWA
A1 ALICJA KUBAN-JANKOWSKA
A1 MAGDALENA GORSKA-PONIKOWSKA
YR 2019
UL http://ar.iiarjournals.org/content/39/3/1243.abstract
AB Background/Aim: Oleuropein belongs to the potent polyphenols of olive oil. Notably, it is considered as a potentially active anticancer agent. Herein, the anticancer efficiency of oleuropein, when used separately and in combination with the chemotherapeutic agent, 2-methoxyestradiol (2-ME), was investigated in highly metastatic osteosarcoma (OS) cells. Materials and Methods: Human OS cells (143B OS cell line) were incubated with oleuropein and 2-ME, alone or in combination. Cell viability was determined by the MTT assay. Cell migration assays were used in order to determine the anti-migratory potential of the compounds, while their impact on autophagy was evaluated via the LC3-antibody-based detection assay. The interaction between oleuropein and 2-ME was determined via the CalcuSyn software. Results: Both anti-migratory and anti-proliferative effects of oleuropein were demonstrated on human OS cells. Anticancer effects of oleuropein were significantly enhanced after 2-ME addition. Treatment of 143B OS cell with oleuropein, alone or in combination with 2-ME resulted in induction of autophagy. Conclusion: The obtained data suggest an anticancer effect of oleuropein, alone and in combination with 2-ME, on highly metastatic 143B OS cells. Notably, a synergism between oleuropein and 2-ME towards 143B OS cells was detected. The exact mechanism of this synergism needs to be further investigated; nonetheless, induction of nitro-oxidative stress and/or induction of autophagy are suggested.